Abstract. Cold atmospheric plasma (CAP) has shown its promising application in cancer treatment both in vitro and in vivo. However, the anti-cancer mechanism is still largely unknown. Introduction.
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Cancer cells have shown specific vulnerabilities to CAP [12] . Understanding the vulnerability of cancer cells to CAP will provide key guidelines for its application in cancer treatment. Two general trends about the cancer cells' vulnerability to CAP treatment have been observed in vitro. First, the cancer cells expressing the p53 gene are more resistant to CAP treatment than p53 minus cancer cells [13] . p53, a key tumor suppressor gene, not only restricts abnormal cells via the induction of growth arrest or apoptosis, but also protects the genome from the oxidative damage of ROS such as H2O2 through regulating the intracellular redox state [14] . p53 is an upstream regulator of the expression of many anti-oxidant enzymes such as glutathione peroxidase (GPX), glutaredoxin 3 (Grx3), and manganese superoxide dismutase (MnSOD) [15] . In addition, cancer cells with a lower proliferation rate are more resistant to CAP than cancer cells with a higher proliferation rate [16] .
This trend may be due to the general observation that the loss of p53 is a key step during tumorigenesis [17] . Tumors at a high tumorigenic stage are more likely to have lost p53 [17] .
Despite the complicated interaction between CAP and cancer cells, the initial several hours after treatment has been found to be an important stage for the cytotoxicity of CAP. The anti-cancer ROS molecules in the extracellular medium are completely consumed by cells during this time period [12] . After the initial several hours, replacing the medium surrounding the cancer cells does not change the cytotoxicity of CAP [18] . Here, we first demonstrate that the H2O2 consumption speed of cancer cells after CAP treatment is a key factor determining the specific vulnerability of cancer cell lines to CAP. The higher H2O2 consumption speed of cancer cells during the initial 3 hours after CAP treatment, results in a less degree of cytotoxicity with CAP treatment. Cancer cells having the capacity to quickly clear the extracellular ROS are more likely to survive compared with other cells which consume the extracellular ROS more slowly. 4 
Methods and materials.
CAP device. The CAP device used in this study is a typical CAP jet generator using helium as the carrying gas. The detailed description of this device has been illustrated in previous studies [12, 19] .
Briefly, a violet plasma jet is formed below the main discharge area between a central anode and an annular grounded cathode and flows out a quartz tube with a diameter of 4.5 mm. The discharge is driven by a 30 kHz alternating current voltage (3.02 kV). The flow rate of the carrying gas is 
Results and discussion.
The initial several hours are the most important stage for determining the cytotoxicity of CAP on cancer cells [10, 12, 18] . Our previous studies have demonstrated that key reactive species such as H2O2 in the medium is completely consumed by glioblastoma cells in just 3 hours [10, 12, 18] . Here, we comprehensively compared the H2O2 consumption speeds of 10 cancer cell lines during their initial 3 hours cultured in the CAP-stimulated medium, which was used to quantify the ROSscavenging ability of cancer cells. We measured the residual H2O2 in the medium surrounding the cells every hour after treatment for 3 hours. The relative residual H2O2 concentration was obtained by the division between the residual H2O2 concentration and the initial H2O2 generation in DMEM. 7 We found that the H2O2 consumption speed is cell specific. In the CAP-treated DMEM, B16F10 cells and SK-OV-3 cells consume H2O2 fastest among all 10 cell lines (Fig. 1a) . B16F10 cells and SK-OV-3 cells clear all extracellular H2O2 in only 2 hours. U2 OS cells consume extracellular H2O2 the slowest (Fig. 1a) . U2 OS cells only consume about 70% of extracellular H2O2 in three hours after CAP treatment. In addition, PA-TU-8998T, MCF-7 HCT116, and IGROV-1 cells have a similar but higher H2O2 consumption rates compared to U2 OS cells (Fig. 1a) .
In addition, the 10 cancer cell lines showed specific vulnerability to direct CAP treatment. Due to the potential cell-based H2O2 generation during direct CAP treatment, the CAP device was used at a relatively low discharge voltage (3.02 kV). At such a low voltage, the cell-based H2O2
generation can be inhibited [20] . Thus, the initial reactive species input from CAP is the same among all cell lines. Among these cell lines, B16F10 and SK-OV-3 cells are most resistant to CAP treatment (Fig. 1b) . A 3 min of CAP treatment led to only a 50% inhibition of cell viability in B16F10 cells compared with control. In contrast, U2OS, PA-TU-8998T, MCF-7, and HCT116 cells are the most vulnerable to direct CAP treatment (Fig. 1b) . Clearly, these cancer cell lines have the least extracellular H2O2 consumption rates (Fig. 1a) . The remaining cell lines generally follow this trend, in that the extracellular ROS scavenging ability of cancer cells is inversely proportional to their vulnerabilities to CAP treatment. The original data with standard deviation are shown in supporting materials ( Fig. S1 and S2 ).
This trend was preserved when cancer cell lines were grown in H2O2-containing medium. All 10 cancer cells showed nearly the same specific H2O2 consumption rates in the H2O2-containing medium as that observed in the CAP-stimulated medium (Fig. 2a) . Similar, the vulnerability of cancer cells to H2O2 treatment is also inversely proportional to the H2O2 consumption rate of cancer cells (Fig. 2b) . For example, B16F10 cells, simultaneously has the strongest H2O2-scavenging capacity and the strongest resistance to H2O2 treatment. As we observed in previous studies, however, CAP treatment cannot be regarded as a simple H2O2 treatment [12] . B16F10 cells are much more resistant to H2O2 treatment than all other cell lines include-ing SK-OV-3 cells (Fig. 2b) . Instead, the vulnerability difference between B16F10 cells and SK-OV-3 cells during H2O2 treatment are much larger than that observed during CAP treatment. This difference may be due to the complicated ROS and RNS components generated in CAP treatment, which will never be generated by just a H2O2 treatment [21, 22] . Nonetheless, the same trends observed in Fig. 1 and shown in supporting materials (Fig. S3 and S4 ).
The correlation between the H2O2 consumption potential of cancer cells and the cytotoxicity of CAP treatment or H2O2 treatment on cancer cells is summarized and shown in Fig. 3 . The inversely proportional correlation between the H2O2 consumption rate and the cytotoxicity of CAP is more pronounced in the case of the CAP treatment ( Fig. 3a) than that of the H2O2 treatment (Fig. 3b) .
Our finding provides a simple cellular marker to predict the cytotoxicity of CAP treatment on different cancer cells. To date, investigating the expression of p53 gene in cancer cells is the only general method to predict the specific cytotoxicity of CAP treatment. The cancer cells expressing p53 gene tend to be more resistant to CAP treatment compared to the cells without the p53 gene [13] . However, this strategy needs complicated biochemical analysis such as western blot and PCR.
In contrast, our strategy needs only a measure of the extracellular H2O2 generation during the initial several hours including the first hour post CAP treatment. This is the first attempt to connect the previous observed complicated vulnerabilities of different cancer cells to CAP treatment with a clear but easily measurable cellular feature.
The H2O2 consumption speed of cancer cells may be the explanation at the cellular level for the correlation between the expression of p53 gene and the specific cytotoxicity of CAP treatment.
p53 regulates the expression of the anti-oxidant system [15] . Thus, the vulnerability of cancer cells 12 to CAP treatment may be significantly affected by the intracellular anti-oxidant system. For example, A549 and U87MG cells are known as peroxide-resistant cell lines [23] . The overexpression of the bcl-2 and the related bcl-xL protooncogene proteins and catalase may contribute to their H2O2-resistant feature through inhibiting apoptosis induced by oxidants and the scavenging intracellular H2O2, respectively [23] . The catalase activity is a major determinant of the cellular resistance to H2O2 toxicity [24] . The specific catalase expression levels in cancer cells 
